PMC:7417114 / 55853-56175 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T272","span":{"begin":0,"end":7},"obj":"Body_part"},{"id":"T273","span":{"begin":93,"end":99},"obj":"Body_part"},{"id":"T274","span":{"begin":100,"end":108},"obj":"Body_part"},{"id":"T275","span":{"begin":187,"end":191},"obj":"Body_part"}],"attributes":[{"id":"A272","pred":"fma_id","subj":"T272","obj":"http://purl.org/sig/ont/fma/fma85272"},{"id":"A273","pred":"fma_id","subj":"T273","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A274","pred":"fma_id","subj":"T274","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A275","pred":"fma_id","subj":"T275","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"capsule orally once daily for 21 days followed by one week drug abstinence;\nbinding to human plasma proteins accounts=85% of administered dose There is a small risk of potentially severe lung inflammation in palbociclib-treated patients.\nAbemaciclib (Verzenio and Verzenios)\n(Eli Lilly) Following oral dose 200 mg,Cmax=158"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T83","span":{"begin":0,"end":7},"obj":"Body_part"},{"id":"T84","span":{"begin":187,"end":191},"obj":"Body_part"}],"attributes":[{"id":"A83","pred":"uberon_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/UBERON_0003893"},{"id":"A84","pred":"uberon_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"capsule orally once daily for 21 days followed by one week drug abstinence;\nbinding to human plasma proteins accounts=85% of administered dose There is a small risk of potentially severe lung inflammation in palbociclib-treated patients.\nAbemaciclib (Verzenio and Verzenios)\n(Eli Lilly) Following oral dose 200 mg,Cmax=158"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T532","span":{"begin":192,"end":204},"obj":"Disease"}],"attributes":[{"id":"A532","pred":"mondo_id","subj":"T532","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"}],"text":"capsule orally once daily for 21 days followed by one week drug abstinence;\nbinding to human plasma proteins accounts=85% of administered dose There is a small risk of potentially severe lung inflammation in palbociclib-treated patients.\nAbemaciclib (Verzenio and Verzenios)\n(Eli Lilly) Following oral dose 200 mg,Cmax=158"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T624","span":{"begin":87,"end":92},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T625","span":{"begin":93,"end":99},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T626","span":{"begin":152,"end":153},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T627","span":{"begin":187,"end":191},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T628","span":{"begin":187,"end":191},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"capsule orally once daily for 21 days followed by one week drug abstinence;\nbinding to human plasma proteins accounts=85% of administered dose There is a small risk of potentially severe lung inflammation in palbociclib-treated patients.\nAbemaciclib (Verzenio and Verzenios)\n(Eli Lilly) Following oral dose 200 mg,Cmax=158"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T49","span":{"begin":59,"end":63},"obj":"Chemical"},{"id":"T43402","span":{"begin":100,"end":108},"obj":"Chemical"},{"id":"T80590","span":{"begin":208,"end":219},"obj":"Chemical"}],"attributes":[{"id":"A17624","pred":"chebi_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A71189","pred":"chebi_id","subj":"T43402","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A62113","pred":"chebi_id","subj":"T80590","obj":"http://purl.obolibrary.org/obo/CHEBI_85993"}],"text":"capsule orally once daily for 21 days followed by one week drug abstinence;\nbinding to human plasma proteins accounts=85% of administered dose There is a small risk of potentially severe lung inflammation in palbociclib-treated patients.\nAbemaciclib (Verzenio and Verzenios)\n(Eli Lilly) Following oral dose 200 mg,Cmax=158"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1581","span":{"begin":87,"end":92},"obj":"Species"},{"id":"1582","span":{"begin":228,"end":236},"obj":"Species"}],"attributes":[{"id":"A1581","pred":"tao:has_database_id","subj":"1581","obj":"Tax:9606"},{"id":"A1582","pred":"tao:has_database_id","subj":"1582","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"capsule orally once daily for 21 days followed by one week drug abstinence;\nbinding to human plasma proteins accounts=85% of administered dose There is a small risk of potentially severe lung inflammation in palbociclib-treated patients.\nAbemaciclib (Verzenio and Verzenios)\n(Eli Lilly) Following oral dose 200 mg,Cmax=158"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T167","span":{"begin":192,"end":204},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"capsule orally once daily for 21 days followed by one week drug abstinence;\nbinding to human plasma proteins accounts=85% of administered dose There is a small risk of potentially severe lung inflammation in palbociclib-treated patients.\nAbemaciclib (Verzenio and Verzenios)\n(Eli Lilly) Following oral dose 200 mg,Cmax=158"}

{"project":"LitCovid-sentences","denotations":[{"id":"T463","span":{"begin":76,"end":237},"obj":"Sentence"},{"id":"T464","span":{"begin":238,"end":274},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"capsule orally once daily for 21 days followed by one week drug abstinence;\nbinding to human plasma proteins accounts=85% of administered dose There is a small risk of potentially severe lung inflammation in palbociclib-treated patients.\nAbemaciclib (Verzenio and Verzenios)\n(Eli Lilly) Following oral dose 200 mg,Cmax=158"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T2209","span":{"begin":0,"end":322},"obj":"SP_7"}],"text":"capsule orally once daily for 21 days followed by one week drug abstinence;\nbinding to human plasma proteins accounts=85% of administered dose There is a small risk of potentially severe lung inflammation in palbociclib-treated patients.\nAbemaciclib (Verzenio and Verzenios)\n(Eli Lilly) Following oral dose 200 mg,Cmax=158"}